Research output per year
Research output per year
Personal profile
Research interests
Leukemia, stem cell mobilization, glioblastoma
Clinical interests
Leukemia, MDS, brain tumors, melanoma oncology
Fingerprint
Dive into the research topics where George Ansstas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas with Somatic NF2 Mutations
Brastianos, P. K., Twohy, E. L., Gerstner, E. R., Kaufmann, T. J., Iafrate, A. J., Lennerz, J., Jeyapalan, S., Piccioni, D. E., Monga, V., Fadul, C. E., Schiff, D., Taylor, J. W., Chowdhary, S. A., Bettegowda, C., Ansstas, G., De La Fuente, M., Anderson, M. D., Shonka, N., Damek, D., Carrillo, J., & 25 others, Jan 20 2023, In: Journal of Clinical Oncology. 41, 3, p. 618-628 11 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination with Extension of Survival among Patients with Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial
Liau, L. M., Ashkan, K., Brem, S., Campian, J. L., Trusheim, J. E., Iwamoto, F. M., Tran, D. D., Ansstas, G., Cobbs, C. S., Heth, J. A., Salacz, M. E., D'Andre, S., Aiken, R. D., Moshel, Y. A., Nam, J. Y., Pillainayagam, C. P., Wagner, S. A., Walter, K. A., Chaudhary, R., Goldlust, S. A., & 53 others, Jan 19 2023, In: JAMA oncology. 9, 1, p. 112-121 10 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations -
Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)
Khaddour, K., Dowling, J., Huang, J., Council, M., Chen, D., Cornelius, L., Johanns, T., Dahiya, S. & Ansstas, G., Feb 11 2023, In: Oncotarget. 14, p. 126 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma
Damato, A. R., Katumba, R. G. N., Luo, J., Atluri, H., Talcott, G. R., Govindan, A., Slat, E. A., Weilbaecher, K. N., Tao, Y., Huang, J., Butt, O. H., Ansstas, G., Johanns, T. M., Chheda, M. G., Herzog, E. D., Rubin, J. B. & Campian, J., May 1 2022, In: Neuro-Oncology Practice. 9, 3, p. 193-200 8 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Mehnert, J. M., Mitchell, T. C., Huang, A. C., Aleman, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L., Carberry, M., Frey, N., Kossenkov, A., Groisberg, R., Hernandez-Aya, L. F., Ansstas, G., Silk, A. W., Chandra, S., Sosman, J. A., Gimotty, P. A., & 2 others, Mar 15 2022, In: Clinical Cancer Research. 28, 6, p. 1098-1106 9 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations